CROSS COUNTRY HEALTHCARE INC - Common Stock, par value $0.0001 per share (CCRN)

Historical Holders from Q1 2014 to Q3 2025

Symbol
CCRN on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
32,768,353
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
31,687,250
Holdings value
$450,046,177
% of all portfolios
0.002%
Number of holders
165
Number of buys
79
Number of sells
-93
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CROSS COUNTRY HEALTHCARE INC - Common Stock, par value $0.0001 per share (CCRN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.5% -13.3% $32,212,933 -$5,237,017 2,468,424 -14% BlackRock, Inc. 30 Jun 2025
ALLIANCEBERNSTEIN L.P. 5.9% -17.1% $27,416,238 -$5,861,235 1,930,721 -17.6% AllianceBernstein L.P. 30 Sep 2025
VANGUARD GROUP INC 5.67% $25,551,128 1,832,936 The Vanguard Group 31 Dec 2024
Magnetar Financial LLC 4.98% -9.3% $20,594,124 -$2,318,016 1,631,864 -10.1% Magnetar Financial LLC 08 Dec 2025
GOLDMAN SACHS GROUP INC 3.9% -31.7% $18,057,017 -$8,745,113 1,271,620 -32.6% THE GOLDMAN SACHS GROUP, INC. 30 Sep 2025

Institutional Holders of CROSS COUNTRY HEALTHCARE INC - Common Stock, par value $0.0001 per share (CCRN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 31,687,250 $450,046,177 +$3,201,884 $14.2 165
2025 Q2 31,504,997 $411,222,338 -$9,167,194 $13.05 159
2025 Q1 31,987,957 $476,365,692 -$6,896,154 $14.89 158
2024 Q4 31,763,189 $576,807,920 -$26,576,295 $18.16 174
2024 Q3 34,428,222 $462,481,461 +$2,428,663 $13.44 178
2024 Q2 34,572,008 $478,509,490 -$18,081,269 $13.84 162
2024 Q1 35,555,762 $665,618,904 -$21,624,815 $18.72 173
2023 Q4 36,869,415 $834,711,162 -$8,741,395 $22.64 173
2023 Q3 37,136,979 $920,623,664 -$13,115,165 $24.79 187
2023 Q2 37,009,862 $1,039,233,444 -$3,624,973 $28.08 190
2023 Q1 37,743,386 $842,372,865 +$31,959,348 $22.32 198
2022 Q4 35,917,572 $954,498,475 -$17,467,658 $26.57 230
2022 Q3 36,487,662 $1,035,192,856 +$18,308,369 $28.37 190
2022 Q2 36,013,006 $750,085,709 +$20,609,097 $20.83 173
2022 Q1 35,413,942 $767,327,226 +$23,176,130 $21.67 189
2021 Q4 34,022,608 $943,371,976 -$13,994,614 $27.76 180
2021 Q3 34,261,975 $727,537,294 +$5,845,611 $21.24 155
2021 Q2 34,136,940 $563,692,367 +$2,732,323 $16.51 145
2021 Q1 34,056,118 $425,425,640 +$10,999,576 $12.49 127
2020 Q4 33,242,318 $294,881,895 -$5,246,529 $8.87 120
2020 Q3 34,028,181 $220,783,385 -$577,784 $6.49 115
2020 Q2 34,196,745 $210,673,003 -$9,160,509 $6.16 120
2020 Q1 35,442,444 $238,838,726 -$1,886,194 $6.74 135
2019 Q4 35,325,914 $410,361,986 +$5,763,378 $11.62 135
2019 Q3 35,026,559 $360,788,377 +$1,988,909 $10.3 129
2019 Q2 34,994,780 $327,317,018 +$3,643,704 $9.38 119
2019 Q1 35,104,033 $246,792,414 +$17,614,189 $7.03 128
2018 Q4 32,496,508 $238,641,926 -$9,096,085 $7.33 140
2018 Q3 33,650,995 $293,775,190 +$4,335,783 $8.73 131
2018 Q2 32,728,475 $368,232,924 -$24,130,956 $11.25 136
2018 Q1 34,910,888 $387,885,595 +$2,693,896 $11.11 132
2017 Q4 34,440,967 $439,780,690 +$9,358,242 $12.76 141
2017 Q3 33,590,105 $477,912,751 -$14,032,136 $14.23 148
2017 Q2 34,853,975 $449,926,590 +$11,753,704 $12.91 141
2017 Q1 33,956,039 $487,604,986 +$77,519,692 $14.36 151
2016 Q4 32,268,281 $503,526,845 +$4,065,021 $15.61 155
2016 Q3 32,442,238 $382,065,320 +$5,990,268 $11.78 143
2016 Q2 31,796,502 $442,560,356 -$643,481 $13.92 145
2016 Q1 32,194,247 $374,397,105 -$5,055,233 $11.63 150
2015 Q4 31,817,035 $521,421,497 +$38,611,882 $16.39 164
2015 Q3 30,527,265 $415,467,095 +$7,763,382 $13.61 140
2015 Q2 30,062,763 $381,184,751 -$6,457,970 $12.68 123
2015 Q1 30,623,486 $362,970,200 +$9,345,046 $11.86 118
2014 Q4 29,764,106 $371,193,521 -$276,957 $12.48 123
2014 Q3 30,012,485 $278,724,742 +$8,932,003 $9.29 122
2014 Q2 29,010,977 $189,219,994 -$9,304,466 $6.52 115
2014 Q1 29,954,010 $241,383,896 +$8,724,067 $8.07 119